How Does Fingolimod (Gilenya(®)) Fit in the Treatment Algorithm for Highly Active Relapsing-Remitting Multiple Sclerosis?

Multiple sclerosis (MS) is a neurological disorder characterized by inflammatory demyelination and neurodegeneration in the central nervous system. Until recently, disease-modifying treatment was based on agents requiring parenteral delivery, thus limiting long-term compliance. Basic treatments such...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fazekas, Franz, Bajenaru, Ovidiu, Berger, Thomas, Fabjan, Tanja Hojs, Ledinek, Alenka Horvat, Jakab, Gábor, Komoly, Samuel, Kobys, Tetiana, Kraus, Jörg, Kurča, Egon, Kyriakides, Theodoros, Lisý, L'ubomír, Milanov, Ivan, Nehrych, Tetyana, Moskovko, Sergii, Panayiotou, Panayiotis, Jazbec, Saša Šega, Sokolova, Larysa, Taláb, Radomír, Traykov, Latchezar, Turčáni, Peter, Vass, Karl, Vella, Norbert, Voloshyná, Nataliya, Havrdová, Eva
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2013
Assuntos:
Neuroscience
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3640198/
https://ncbi.nlm.nih.gov/pubmed/23641231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2013.00010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados